E for L Aim Past Earnings Performance
Past criteria checks 2/6
E for L Aim has been growing earnings at an average annual rate of 30.3%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been declining at an average rate of 9.1% per year. E for L Aim's return on equity is 0.1%, and it has net margins of 0.06%.
Key information
30.3%
Earnings growth rate
33.6%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | -9.1% |
| Return on equity | 0.1% |
| Net Margin | 0.06% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How E for L Aim makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,216 | 1 | 387 | 0 |
| 30 Jun 24 | 1,156 | -23 | 385 | 0 |
| 31 Mar 24 | 1,271 | 12 | 396 | 0 |
| 31 Dec 23 | 1,310 | 13 | 404 | 0 |
| 30 Sep 23 | 1,380 | 25 | 414 | 0 |
| 30 Jun 23 | 1,410 | 22 | 437 | 0 |
| 31 Mar 23 | 1,438 | 17 | 438 | 0 |
| 31 Dec 22 | 1,492 | 53 | 429 | 0 |
| 30 Sep 22 | 1,613 | 69 | 424 | 0 |
| 30 Jun 22 | 1,880 | 716 | 442 | 0 |
| 31 Mar 22 | 2,089 | 791 | 455 | 0 |
| 31 Dec 21 | 2,165 | 812 | 460 | 0 |
| 30 Sep 21 | 2,110 | 798 | 468 | 0 |
| 30 Jun 21 | 1,926 | 195 | 454 | 0 |
| 31 Mar 21 | 1,761 | 128 | 451 | 0 |
| 31 Dec 20 | 1,667 | -299 | 503 | 0 |
| 30 Sep 20 | 1,651 | -545 | 600 | 0 |
| 30 Jun 20 | 1,706 | -610 | 677 | 0 |
| 31 Mar 20 | 1,756 | -655 | 752 | 0 |
| 31 Dec 19 | 1,921 | -273 | 755 | 0 |
| 30 Sep 19 | 2,088 | -314 | 706 | 0 |
| 30 Jun 19 | 2,114 | -297 | 673 | 0 |
| 31 Mar 19 | 2,099 | -277 | 640 | 0 |
| 31 Dec 18 | 2,060 | -164 | 684 | 0 |
| 30 Sep 18 | 2,156 | -918 | 752 | 0 |
| 30 Jun 18 | 2,222 | -946 | 804 | 0 |
| 31 Mar 18 | 2,256 | -984 | 853 | 0 |
| 31 Dec 17 | 2,474 | -1,112 | 824 | 0 |
| 30 Sep 17 | 2,845 | -577 | 963 | 0 |
| 30 Jun 17 | 3,100 | -601 | 954 | 0 |
| 31 Mar 17 | 3,494 | -606 | 978 | 0 |
| 31 Dec 16 | 3,673 | -614 | 994 | 0 |
| 30 Sep 16 | 3,710 | -80 | 776 | 0 |
| 30 Jun 16 | 3,964 | -1 | 778 | 0 |
| 31 Mar 16 | 4,177 | 72 | 765 | 0 |
| 31 Dec 15 | 4,504 | 210 | 726 | 0 |
| 30 Sep 15 | 4,076 | 236 | 707 | 0 |
| 30 Jun 15 | 3,300 | 286 | 550 | 0 |
| 31 Mar 15 | 2,421 | 316 | 361 | 0 |
| 31 Dec 14 | 1,450 | 256 | 242 | 0 |
| 30 Sep 14 | 861 | 207 | 124 | 0 |
| 30 Jun 14 | 553 | 128 | 88 | 0 |
| 31 Mar 14 | 342 | 73 | 66 | 0 |
| 31 Dec 13 | 158 | 26 | 39 | 0 |
Quality Earnings: EFORL has high quality earnings.
Growing Profit Margin: EFORL's current net profit margins (0.06%) are lower than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EFORL has become profitable over the past 5 years, growing earnings by 30.3% per year.
Accelerating Growth: EFORL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: EFORL had negative earnings growth (-97.1%) over the past year, making it difficult to compare to the Healthcare industry average (11.1%).
Return on Equity
High ROE: EFORL's Return on Equity (0.1%) is considered low.